Provided by Tiger Fintech (Singapore) Pte. Ltd.

Apellis Pharmaceuticals Inc.

22.95
+0.61002.73%
Post-market: 23.040.0944+0.41%19:42 EDT
Volume:4.08M
Turnover:94.14M
Market Cap:2.88B
PE:-12.78
High:23.57
Open:22.26
Low:22.04
Close:22.34
Loading ...
Jul 31, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2025

Major Issues Report

Form 8-K - Current report
Jun 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities